The chief executive of Takeda Pharmaceutical struck back against shareholders angry about his plan to appoint a foreigner as president, saying the move was necessary for global growth.
from WSJ.com: US Business http://ift.tt/1qR1rQa
via IFTTT
from WSJ.com: US Business http://ift.tt/1qR1rQa
via IFTTT
No comments:
Post a Comment